Literature DB >> 24378436

Cell-based flow cytometry assay to measure cytotoxic activity.

Alessandra Noto1, Pearline Ngauv1, Lydie Trautmann2.   

Abstract

Cytolytic activity of CD8+ T cells is rarely evaluated. We describe here a new cell-based assay to measure the capacity of antigen-specific CD8+ T cells to kill CD4+ T cells loaded with their cognate peptide. Target CD4+ T cells are divided into two populations, labeled with two different concentrations of CFSE. One population is pulsed with the peptide of interest (CFSE-low) while the other remains un-pulsed (CFSE-high). Pulsed and un-pulsed CD4+ T cells are mixed at an equal ratio and incubated with an increasing number of purified CD8+ T cells. The specific killing of autologous target CD4+ T cells is analyzed by flow cytometry after coculture with CD8+ T cells containing the antigen-specific effector CD8+ T cells detected by peptide/MHCI tetramer staining. The specific lysis of target CD4+ T cells measured at different effector versus target ratios, allows for the calculation of lytic units, LU₃₀/10(6) cells. This simple and straightforward assay allows for the accurate measurement of the intrinsic capacity of CD8+ T cells to kill target CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24378436      PMCID: PMC4111270          DOI: 10.3791/51105

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.

Authors:  Estelle Devêvre; Pedro Romero; Yolanda D Mahnke
Journal:  J Immunol Methods       Date:  2006-02-24       Impact factor: 2.303

2.  Calculation of lytic units for the expression of cell-mediated cytotoxicity.

Authors:  J Bryant; R Day; T L Whiteside; R B Herberman
Journal:  J Immunol Methods       Date:  1992-01-21       Impact factor: 2.303

3.  Phenotype and function of protective T cell immune responses in HIV.

Authors:  Michael R Betts; Alexandre Harari
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

4.  Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection.

Authors:  Lydie Trautmann; Florentin-Martial Mbitikon-Kobo; Jean-Philippe Goulet; Yoav Peretz; Yu Shi; Julien Van Grevenynghe; Francesco Andrea Procopio; Mohamad Rachid Boulassel; Jean-Pierre Routy; Nicolas Chomont; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

5.  A high-throughput single-cell analysis of human CD8⁺ T cell functions reveals discordance for cytokine secretion and cytolysis.

Authors:  Navin Varadarajan; Boris Julg; Yvonne J Yamanaka; Huabiao Chen; Adebola O Ogunniyi; Elizabeth McAndrew; Lindsay C Porter; Alicja Piechocka-Trocha; Brenna J Hill; Daniel C Douek; Florencia Pereyra; Bruce D Walker; J Christopher Love
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

6.  Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells.

Authors:  Florentin-Martial Mbitikon-Kobo; Marc Bonneville; Rafick-Pierre Sekaly; Lydie Trautmann
Journal:  J Immunol Methods       Date:  2011-10-05       Impact factor: 2.303

7.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  A new immunodeficiency disorder in humans involving NK cells.

Authors:  J C Roder; T Haliotis; M Klein; S Korec; J R Jett; J Ortaldo; R B Heberman; P Katz; A S Fauci
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

9.  Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Authors:  Anthony M Byers; Christopher C Kemball; Janice M Moser; Aron E Lukacher
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  High efficiency of antiviral CD4(+) killer T cells.

Authors:  Steven K Hildemann; Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Dirk Homann
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  9 in total

Review 1.  Kill: boosting HIV-specific immune responses.

Authors:  Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

2.  Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

3.  Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.

Authors:  Denis Comte; Maria P Karampetsou; Nobuya Yoshida; Katalin Kis-Toth; Vasileios C Kyttaris; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2017-05       Impact factor: 10.995

4.  Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.

Authors:  Mohammed F Alosaimi; Manfred Hoenig; Faris Jaber; Craig D Platt; Jennifer Jones; Jacqueline Wallace; Klaus-Michael Debatin; Ansgar Schulz; Eva Jacobsen; Peter Möller; Hanan E Shamseldin; Ferdous Abdulwahab; Niema Ibrahim; Hosam Alardati; Faisal Almuhizi; Ibraheem F Abosoudah; Talal A Basha; Janet Chou; Fowzan S Alkuraya; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2019-03-11       Impact factor: 10.793

5.  A purine metabolic checkpoint that prevents autoimmunity and autoinflammation.

Authors:  Svetlana Saveljeva; Gavin W Sewell; Katharina Ramshorn; M Zaeem Cader; James A West; Simon Clare; Lea-Maxie Haag; Rodrigo Pereira de Almeida Rodrigues; Lukas W Unger; Ana Belén Iglesias-Romero; Lorraine M Holland; Christophe Bourges; Muhammad N Md-Ibrahim; James O Jones; Richard S Blumberg; James C Lee; Nicole C Kaneider; Trevor D Lawley; Allan Bradley; Gordon Dougan; Arthur Kaser
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

6.  Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Authors:  Lien Van Hoecke; Emma Richelle Job; Xavier Saelens; Kenny Roose
Journal:  J Vis Exp       Date:  2017-05-04       Impact factor: 1.355

7.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

8.  Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance.

Authors:  Manuel Wiesinger; Johannes März; Mirko Kummer; Gerold Schuler; Jan Dörrie; Beatrice Schuler-Thurner; Niels Schaft
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.639

9.  Divergent fates of antigen-specific CD8+ T cell clones in mice with acute leukemia.

Authors:  Xiufen Chen; Brendan W MacNabb; Blake Flood; Bruce R Blazar; Justin Kline
Journal:  Cell Rep       Date:  2021-11-09       Impact factor: 9.995

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.